DE MARTINO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 124
AS - Asia 66
EU - Europa 66
SA - Sud America 16
AF - Africa 1
Totale 273
Nazione #
US - Stati Uniti d'America 123
SG - Singapore 40
IT - Italia 32
DE - Germania 13
BR - Brasile 11
CN - Cina 10
VN - Vietnam 8
GB - Regno Unito 6
SE - Svezia 6
AT - Austria 3
IN - India 3
CO - Colombia 2
EE - Estonia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
CA - Canada 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
FI - Finlandia 1
HK - Hong Kong 1
NL - Olanda 1
PK - Pakistan 1
PS - Palestinian Territory 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 273
Città #
Dallas 63
Singapore 29
Munich 12
Santa Clara 8
Hefei 7
Chandler 6
Milan 6
Boardman 4
Carrara 4
Ashburn 3
Ho Chi Minh City 3
Lawrence 3
London 3
Princeton 3
Borgia 2
Casoria 2
Chicago 2
Ginosa 2
Hanoi 2
Los Angeles 2
Marino 2
Morciano di Leuca 2
New York 2
São Paulo 2
Xian 2
Ajman 1
Altamira 1
Amsterdam 1
Baku 1
Belo Horizonte 1
Benevento 1
Buffalo 1
Campinas 1
Catu 1
Coyhaique 1
Crotone 1
Curitiba 1
Céu Azul 1
Des Moines 1
Haiphong 1
Hong Kong 1
Jinhua 1
Johannesburg 1
Joinville 1
Keswick 1
Medellín 1
Montanha 1
Multan 1
New Delhi 1
Newcastle upon Tyne 1
Norwalk 1
Nuremberg 1
Quito 1
Quảng Ninh 1
Quận Phú Nhuận 1
Ramallah 1
Rome 1
San Francisco 1
San Jose 1
San Juan Bautista 1
Santa Maria 1
Saratov 1
Topeka 1
Turku 1
Wilmington 1
Totale 216
Nome #
Microstructural alterations of the spinothalamic tract and neuropathic pain: A diffusion tensor imaging study in relapsing remitting multiple sclerosis 74
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era 49
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 38
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 37
Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic 26
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 24
CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab 22
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab 11
null 1
Totale 282
Categoria #
all - tutte 2.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 1 4 0 1 1 5 8 0 0
2021/202213 0 1 0 4 3 1 0 1 1 1 1 0
2022/202323 6 2 2 1 0 1 0 2 3 3 2 1
2023/202418 2 6 3 1 0 1 0 0 2 0 0 3
2024/202579 9 0 0 7 6 11 3 1 9 4 7 22
2025/2026129 24 43 62 0 0 0 0 0 0 0 0 0
Totale 282